INVESTIGATING ASCL1-DRIVEN IMMUNOLOGICAL LANDSCAPES IN NEUROENDOCRINE PROSTATE CANCER: A STRATEGY FOR ENHANCING IMMUNOTHERAPY EFFICACY

The University Of British Columbia

Investigators